These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 54684)

  • 1. Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats?
    Möhring J; Möhring B; Petri M; Haack D
    Lancet; 1976 Jan; 1(7952):170-3. PubMed ID: 54684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and malignant deoxycorticosterone hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D
    Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
    Möhring J; Möhring B; Petri M; Haack D
    Am J Physiol; 1977 Mar; 232(3):F260-9. PubMed ID: 842673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension.
    Möhring J; Möhring B; Petri M; Haack D
    Circ Res; 1978 Jan; 42(1):17-22. PubMed ID: 618598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    Clin Exp Pharmacol Physiol; 1982; 9(3):297-301. PubMed ID: 6754178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of vasopressin in the mechanism maintaining hypertension in the rat.
    Yazaki Y; Ohuchi Y; Ashida T; Saito T
    Jpn Circ J; 1981 Sep; 45(9):1116-20. PubMed ID: 7300021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of vasopressin in hypertension: Cause or effect?
    Padfield PL; Brown JJ; Lever AF; Morton JJ; Robertson JI
    Lancet; 1976 Jun; 1(7972):1255-7. PubMed ID: 73691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of saline drinking on malignant course of renal hypertension in rats.
    Möhring J; Petri M; Szokol M; Haack D; Möhring B
    Am J Physiol; 1976 Mar; 230(3):849-57. PubMed ID: 1266989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure.
    Gavras H; Hatzinikolaou P; North WG; Bresnahan M; Gavras I
    Hypertension; 1982; 4(3):400-5. PubMed ID: 7040232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin and vasopressin in the pathogenesis of malignant hypertension].
    Möhring J
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():157-66. PubMed ID: 349924
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of chloride in deoxycorticosterone hypertension: selective sodium loading by diet or drinking fluid.
    Kunes J; Zicha J; Jelínek J
    Physiol Res; 2004; 53(2):149-54. PubMed ID: 15046550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension.
    Sun Z
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1472-7. PubMed ID: 16396942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulation.
    Ganten D; Unger T; Lang RE
    J Pharmacol; 1985; 16 Suppl 2():51-68. PubMed ID: 2867253
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of prolonged vasopressin treatment in Brattleboro rats with diabetes insipidus.
    Möhring J; Kohrs G; Möhring B; Petri M; Homsy E; Haack D
    Am J Physiol; 1978 Feb; 234(2):F106-11. PubMed ID: 623299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renin-angiotensin system in the pathogenesis of severe hypertension in rats.
    Carretero OA; Kuk P; Piwonska S; Houle JA; Marin-Grez M
    Circ Res; 1971 Dec; 29(6):654-63. PubMed ID: 5128290
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.